Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Statistics

Total Valuation

NGM:ABERA has a market cap or net worth of SEK 127.09 million. The enterprise value is 103.60 million.

Market Cap	127.09M
Enterprise Value	103.60M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

NGM:ABERA has 20.50 million shares outstanding. The number of shares has increased by 5.59% in one year.

Current Share Class	20.50M
Shares Outstanding	20.50M
Shares Change (YoY)	+5.59%
Shares Change (QoQ)	+12.08%
Owned by Insiders (%)	4.84%
Owned by Institutions (%)	n/a
Float	19.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.69
PB Ratio	6.59
P/TBV Ratio	6.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.91
EV / Sales	8.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.12

Financial Position

The company has a current ratio of 2.73

Current Ratio	2.73
Quick Ratio	2.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.82% and return on invested capital (ROIC) is -47.32%.

Return on Equity (ROE)	-74.82%
Return on Assets (ROA)	-31.36%
Return on Invested Capital (ROIC)	-47.32%
Return on Capital Employed (ROCE)	-54.85%
Weighted Average Cost of Capital (WACC)	9.54%
Revenue Per Employee	2.38M
Profits Per Employee	-2.09M
Employee Count	5
Asset Turnover	0.56
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.32% in the last 52 weeks. The beta is 0.96, so NGM:ABERA's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-0.32%
50-Day Moving Average	6.42
200-Day Moving Average	7.06
Relative Strength Index (RSI)	47.22
Average Volume (20 Days)	25,698

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:ABERA had revenue of SEK 11.89 million and -10.45 million in losses. Loss per share was -0.63.

Revenue	11.89M
Gross Profit	11.89M
Operating Income	-10.58M
Pretax Income	-10.45M
Net Income	-10.45M
EBITDA	-10.39M
EBIT	-10.58M
Loss Per Share	-0.63

Balance Sheet

The company has 23.49 million in cash and n/a in debt, with a net cash position of 23.49 million or 1.15 per share.

Cash & Cash Equivalents	23.49M
Total Debt	n/a
Net Cash	23.49M
Net Cash Per Share	1.15
Equity (Book Value)	19.29M
Book Value Per Share	1.04
Working Capital	16.09M

Cash Flow

In the last 12 months, operating cash flow was -3.26 million and capital expenditures -426,000, giving a free cash flow of -3.68 million.

Operating Cash Flow	-3.26M
Capital Expenditures	-426,000
Free Cash Flow	-3.68M
FCF Per Share	-0.18

Margins

Gross margin is 100.00%, with operating and profit margins of -88.99% and -87.94%.

Gross Margin	100.00%
Operating Margin	-88.99%
Pretax Margin	-87.94%
Profit Margin	-87.94%
EBITDA Margin	-87.38%
EBIT Margin	-88.99%
FCF Margin	n/a

Dividends & Yields

NGM:ABERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.59%
Shareholder Yield	-5.59%
Earnings Yield	-8.22%
FCF Yield	-2.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:ABERA has an Altman Z-Score of 3.19 and a Piotroski F-Score of 2.

Altman Z-Score	3.19
Piotroski F-Score	2